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Abstract  20 
 21 
Both in human and equine species, mesenchymal stem cells (MSCs) from amniotic membrane 22 
(AM) and Wharton’s jelly (WJ), may be particularly useful for immediate use or in later 23 
stages of life, after cryopreservation in cell bank. The aim of this study was to compare equine 24 
AM- and WJ-MSCs in vitro features, that may be relevant for their clinical employment. 25 
MSCs were more easily isolated from WJ, even if MSCs derived from AM exhibited most 26 
rapid proliferation (P<0.05). Osteogenic and chondrogenic differentiation was most 27 
prominent in MSCs derived from WJ, as also suggested by the lower adhesion of AM cells, 28 
demonstrated by the greater volume of spheroids after hanging drop culture (P<0.05). Data 29 
obtained by PCR confirmed the immunosuppressive function of AM and WJ-MSCs and the 30 
presence of active genes specific for anti-inflammatory and angiogenic factors (IL-6, IL 8, IL-31 
β1). For the first time, by means of transmission electron microscopy (TEM), we ascertained 32 
that equine WJ-MSCs constitutively contain a very impressive number of large vesicular 33 
structures, scattered throughout the cytoplasm and there was an abundant extracellular 34 
fibrillar matrix located in the intercellular spaces among WJ-MSCs. Results reveal that MSCs 35 
from different fetal tissues have different characteristics that may drive their therapeutic use. 36 
Data recorded in this study could be noteworthy for horses as well as for other mammalian 37 
species, including humans. 38 
Keywords:  39 
Mesenchymal stem cells, amniotic membrane, Wharton’s jelly, equine, electron microscopy 40 
41 
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Introduction 42 
Mesenchymal stem cells (MSCs) are a population of multipotent stem cells and since their 43 
properties, MSCs offer a great chance for cell-based therapies and tissue engineering 44 
applications. Bone marrow (BM) is the common source of autologous MSCs for clinical 45 
applications in equine medicine. Alternatively, adipose tissue-derived MSCs can be used, 46 
since they have a higher proliferation potential (Iacono et al., 2015a). Anyway, for both 47 
sources, an invasive procedure is required and there is a large variability in the cell yield 48 
related to the donor (Colleoni et al., 2009). Furthermore, although bone marrow is the most 49 
widely investigated source of MSCs, these have limited potential in terms of in vitro 50 
proliferation capability (Guest et al., 2010; Lange-Consiglio et al., 2013), and do not appear 51 
to noticeably improve long-term functionality compared to those from extra-fetal tissues 52 
(Paris and Stout, 2010). Placental tissues and foetal fluids represent a source of cells for 53 
regenerative medicine, and are readily available and easily procured without invasive 54 
procedures. MSCs from foetal fluids and adnexa are defined as an intermediate between 55 
embryonic and adult SCs, due to the preservation of some characteristics typical of the 56 
primitive native layers (De Coppi et al., 2007). Among foetal adnexal tissues, the major 57 
sources of MSCs are amniotic membrane and  Wharton’s Jelly (Iacono et al., 2015b). 58 
Althought, the increasing interest in using MSCs for regenerative medicine in horses, and the 59 
possibility to employ MSCs from perinatal tissue both for immediate use in newborns, both in 60 
later stages of life, after cryopreservation in cell bank, there is lacking of information on 61 
comparison between equine MSCs derived from AM and WJ were compared.  62 
Usually, clinical treatments with MSCs are based on their transplantation but only a small 63 
percentage of the injected MSCs engraft successfully (Chimenti et al., 2010). Consistent with 64 
these findings, some studies recently showed that the regenerative ability of MSCs could be 65 
attributed to the production of molecules and mediators capable of activating the intrinsic 66 
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repair processes in the damaged tissues. Different Authors, working on cardiac, renal, spinal 67 
cord and tendon regeneration, indicate that the beneficial effects of MSCs can be attributed to 68 
the activation of paracrine mechanisms enabling stimulation of endogenous stem cells. These 69 
cells are responsible for the bioactive soluble factors (lipids, growth factors, and cytokines) 70 
known to inhibit apoptosis and fibrosis, enhance angiogenesis, stimulate mitosis and/or 71 
differentiation of tissue-resident progenitor cells, and modulate the immune response (Yagi et 72 
al., 2010; Liang et al., 2014).  Recently, the ability of equine adult MSCs to secrete numerous 73 
soluble mediators, implicated in the inhibition of T-cell proliferation, when stimulate with 74 
INF-gamma and TNG-alpha, was demonstrated (Carrade et al., 2012; Kol et al., 2013). 75 
However, to our knowledge, no studies are present on the immunophenotype profile, before in 76 
vitro stimulation, of equine WJ-MSCs and AM-MSCs, to better know their role in the 77 
immune response, angiogenesis, apoptosis, oxidation level and cell migration. Furthermore, in 78 
addition to soluble factors, recent findings indicate that extracellular vesicles are released 79 
from MSCs inside the CM and that these can be involved as important mediators in cell- to-80 
cell communication (Pascucci et al., 2014; Pascucci et al., 2015). Microvesicles (MVs) have 81 
been categorized into exosomes (EXs), released from the endosomal compartment, and 82 
shedding vesicles (SVs), which bud directly from the cell membrane (Biancone et al., 2012). 83 
MVs seem to be involved in a dynamic mutual paracrine communication between the 84 
embryonic and the maternal environment at the early stage of pre-implantation embryo 85 
development (Saadeldin et al., 2015). Recently, Lange-Consiglio et al. (2016) and Perrini et 86 
al. (2016) identified the presence and type of MVs secreted by equine AM-MSCs; the 87 
Authors also evaluated, in a preliminary study in vitro, the possible therapeutic implication of 88 
MVs in endometrial and tendon pathologies. Despite these studies on equine AM-MSCs, the 89 
recognized importance of WJ as an alternative source of MSCs both in equine and human 90 
medicine (Iacono et al., 2012; Subramanian et al., 2015) and despite a lot of data have been 91 
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reported on these features of equine adult MSCs (Pascucci et al., 2010; Maia et al., 2013; 92 
Pascucci et al., 2014; Pascucci et al., 2015), no studies are present on ultrastructural 93 
characteristics and MVs of equine WJ-MSCs. In this context, the aims of the present study 94 
were to analyze expression of stemness markers, immunophenotype, and ultrastructural 95 
features. In addition, we considered migration and adhesion ability of equine WJ-MSCs and 96 
AM-MSCs since both the migration ability, the expression of adhesion molecules and the 97 
homing to injured environments are important features of MSCs (Burk et al., 2013; Kavanagh 98 
et al., 2014).  99 
 100 
Materials and Methods 101 
 102 
Materials 103 
Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich (St. Louis, MO, 104 
USA), and laboratory plastics from Sarstedt Inc. (Newton, NC, USA).  105 
 106 
Animals 107 
Samples were recovered from 13 Standardbred mares, housed at the Department of Veterinary 108 
Medical Sciences, University of Bologna, for attended delivery. Experimental procedures 109 
were approved by the Ethics Committee, University of Bologna (8134-X/10). The written 110 
consent was given by the owners to allow tissues recovery for research purposes. 111 
 112 
Umbilical cord collection and WJ-MSCs isolation 113 
Immediately after breaking the umbilical cord (UC), the part closest to the colt, characterized 114 
by an abundant amount of WJ, was severed. For avoiding mildew and bacterial 115 
contamination, samples were washed under flowing water for removing straw or feces debris. 116 
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Until processing, samples were stored in D-PBS (Dulbecco’s Phosphatase Buffered Solution) 117 
containing penicillin (100 IU/ml) and streptomycin (100 mg/ml), at 4°C for at the latest 12 h. 118 
In the lab, before WJ enzymatic digestion, under a laminal flow hood, UCs were disinfected 119 
by immersing for few seconds in 70% ethanol and rinsed by repeated immersion in D-PBS. 120 
WJ was then isolated, weighed, minced finely (0.5 cm2) by sterile scissors and cells were 121 
isolated as previously described (Iacono et al., 2012). Briefly, WJ fragments were incubated 122 
in a 37 °C water bath for 1-2 h into a 50ml polypropylene tube, containing 1ml/1g sample of 123 
digestion solution (0.1% (w/v) collagenase type I (Gibco, Invitrogen Corporation, Carlsbad, 124 
California, USA), in D-PBS). The mixture was then filtered to separate the dispersed amnion 125 
cells from the tissue pieces and collagenase was inactivated by diluting 1:1 with D-PBS plus 126 
10% (v/v) FBS (Gibco). Nucleated cells were pelleted at 470 g for 10 min. The supernatant 127 
was discarded, pellet was re-suspended in 5 ml of culture medium (Dulbecco’s Modified 128 
Essential Medium (D-MEM)-F12 Glutamax® (Gibco) supplemented with 10% v/v FBS, 100 129 
iu/ml penicillin and 100 µg/ml streptomycin) and spun at 470 g for 10 min to wash cells. This 130 
operation was repeated three times. After the last wash, cell pellet was re-suspended in 1 ml 131 
of culture medium and cell concentration was determined by haemocytometer.  132 
 133 
Amnion collection and cells isolation 134 
Allanto-amniotic membranes were obtained at pregnancy term, after vaginal delivery. 135 
Portions of allanto-amnion were washed under flowing water for removing straw or feces 136 
debris, stored at 4°C in D-PBS, added with antibiotics (100 iu/ml penicillin and 100 µg/ml 137 
streptomycin), and were processed within 12h. In the lab, before enzymatic digestion, under a 138 
laminal flow hood, samples were disinfected by immersing for few seconds in 70% ethanol 139 
and rinsed by repeated immersion in D-PBS. Then, AM was stripped from the overlying 140 
allantois, weighted and cut into small pieces (0.5 cm2) by sterile scissors. Cells were then 141 
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isolated as described above for WJ, by an enzymatic digestion.  142 
 143 
Cell culture and proliferation assays 144 
 145 
After isolation, primary cells derived from all recovered samples were plated in a 25 cm2 flask 146 
in 5 ml of D-MEM-F12 Glutamax®, plus 10% v/v FBS and antibiotics. Cells were incubated 147 
in a 5% CO2 humidified atmosphere at 38.5°C. At ~80-90% of confluence, they were 148 
dissociated by 0.25% trypsin, counted and plated at the concentration of 5x103 cells/cm2 as 149 
“Passage 1” (P1), and so on for the following passages. Calculation of cell-doubling time 150 
(DT) and cell-doubling numbers (CD) was carried out according to the formulae of (Rainaldi 151 
et al., 1991): 152 
CD= ln(Nf/Ni)/ln(2)     (1) 153 
DT= CT/CD       (2) 154 
where Nf  is the final number of cells and Ni the initial number of cells. 155 
 156 
Adhesion and Migration Assays 157 
To define differences between WJ and AM-MSCs, spheroid formation and migration test 158 
were performed. Three replicates for each experiment were performed; all replicates were 159 
carried out at passage 3 of in vitro culture.  160 
For adhesion assay, cells were cultured in ‘hanging drops’ (5.000 cells/drop of 25µl) for 24 h. 161 
Images were acquired by a Nikon Eclipse TE 2000-U microscope. Spheroid areas were 162 
determined using ImageJ software (imagej.nih.gov/ij/). Starting from the binary masks 163 
obtained by Image J, the volume of each spheroid was computed using ReViSP 164 
(sourceforge.net/projects/revisp) (Bellotti et al., 2016), a software specifically designed to 165 
accurately estimate the volume of spheroids and to render an image of their 3D surface.  166 
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To assess cell migration potential, a scratch assay (also known as Wound-Healing assay) was 167 
carried out, as previously described (Liang et al., 2007). Briefly, at 80–90 % confluence the 168 
cell monolayer was scraped using a p1000 pipet tip. After washing twice with D-PBS, the 169 
dish was incubated for 24 h at 38.5 °C and 5 % CO2 in a humidified atmosphere. Images were 170 
acquired both immediately after the tip-scratch (time 0; T0) and after the incubation period 171 
(last time point or time 1; T1), and the distances of each scratch closure were calculated by 172 
ImageJ software. The migration percentages were calculated using the following formula 173 
(Rossi et al., 2014): 174 
[(distance at T0-distance at T1)*100]/distance at T0 175 
176 
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In vitro differentiation 177 
In vitro differentiation potential of cells towards osteogenic, adipogenic and chondrogenic 178 
lineages was studied. Cells (5x103 cells ⁄cm2) were cultured under specific induction media 179 
(Table 1). As negative control, an equal number of cells was cultured in expansion medium. 180 
In vitro differentiation potential was assessed at passage 3 of culture in two replicates for 3 181 
samples from each lineage. To cytologically evaluate differentiation, cells were fixed with 182 
10% formalin at room temperature (RT) and stained with Oil Red O, Alcian Blue and Von 183 
Kossa for adipogenic, chondrogenic and osteogenic induction, respectively. Quantitative 184 
analysis of in vitro differentiation was performed by Image J.  185 
 186 
Immunocytochemistry (ICC) 187 
Cells, derived from 3 AM and WJ samples, at P3, were cultured on ICC slides, until 188 
confluence. They were then fixed with 4 % paraphormaldehyde (20 min at RT) and then 189 
washed in phosphate buffer (PB). Cells were blocked in goat serum (10 %) for 1 h and 190 
incubated overnight with primary antibodies (Table 2); the day after, they were washed in 191 
PB2 (PB + 0.2 % BSA + 0.05 % saponin) and incubated with anti-mouse- or anti-rabbit- 192 
FITC conjugated secondary antibodies for 1 h. Nuclei were then labelled with Hoechst 33342. 193 
The excess of secondary antibody and Hoechst were removed by 3 washes with PB2. Images 194 
were obtained with a Nikon Eclipse E400 microscope, using the software Nikon NIS-195 
Elements.  196 
 197 
Molecular Characterization 198 
To evaluate pluripotency potential of the two types of equine cells, PCR for the pluripotency 199 
genes OCT4, NANOG and SOX2 was performed. Gene expression was tested on equine 200 
blastocysts, as positive control. To test cell stemness and immunoproperty, the following set 201 
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of genes was evaluated: CD45, CD 34, CD90, CD73, MHC-I, MHC-II, IL-b1, IL-4, IL-6, IL-202 
8, INF-g, TNF-a. Primers were tested on activated equine lymphocyte. The specific set of 203 
primers used is listed in Table 3. All tests were carried out on 100x103 cells, derived from 204 
AM and WJ of three different mares. Experiments were performed at passage 3 of culture.  205 
Cells were snap-frozen and RNA was extracted using Nucleo Spin® RNA kit (Macherey-206 
Nagel, Düren, Germany) following the manufacturer’s instructions. cDNAs were synthesized 207 
by RevertAid RT Kit (ThermoFisher Scientific, Waltham, Massachusetts, USA) and used 208 
directly in PCR reactions, following the instructions of Maxima Hot Start PCR Master Mix 209 
(2X) (ThermoFisher Scientific, Waltham, Massachusetts, USA). PCR products were 210 
visualized with ethidium bromide on a 2% agarose gel. 211 
 212 
Transmission Electron Microscopy (TEM) 213 
Ultrastructural examination was performed on AM (n=3) and WJ-MSCs (n=3) at P3. The 214 
analysis was performed on three replicates. After detaching cells, the pellet was fixed with 215 
2.5% glutaraldehyde in 0.1 M PB, pH 7.3, for 1 h, at RT. Cells were then washed twice in PB 216 
and post-fixed with buffered 2% osmium tetroxide for 1 h, at RT. They were finally 217 
dehydrated in a graded ethanol-propylen oxide series, pre-infiltrated and embedded in Epon 218 
812. Ultrathin sections (90 nm) were mounted on 200-mesh copper grids, stained with uranyl 219 
acetate and lead citrate, and examined by a Philips EM 208 microscope, equipped with a 220 
digital camera (Center for Electron Microscopy, CUME, University of Perugia). 221 
 222 
Statistical Analysis 223 
Harvested WJ and AM (grams), CDs, DTs and percentages of migration are expressed as 224 
mean ± standard deviation (SD). Statistical analyses were performed using IBM SPSS 225 
Statistics 21 (IBM Corporation, Armonk, New York, USA). Data were analysed, for normal 226 
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distribution, using a Shapiro-Wilk test, then using one-way ANOVA or a Student’s t-test 227 
(CDs and DTs). The 3D spheroid volumes and mean grey intensity of differentiated cells 228 
were compared using Mann-Whithney’s U-test, due to their non-normal distribution. 229 
Significance was assessed for P<0.05. 230 
 231 
Results 232 
 233 
Cellular Growth 234 
As soon as after foals’ birth and immediately after foal detachment, UC (length ~15 cm) and 235 
AM samples were recovered. The mean weight of recovered jelly and AM were 5.22±3.34 g 236 
and 15.60±5.23 g, respectively. Adherent mononuclear cells, characterized by elongated 237 
fibroblast-like morphology were isolated in 13/13 (100%) WJ samples and in 9/13 (69.2%) 238 
AM samples. Undifferentiated cells of both lines were passaged up to seven times; no 239 
changes in cell morphology was observed throughout the culture period. DTs assay showed 240 
that AM and WJ-MSCs were able to divide for an extensive period in vitro. During P0 to P7, 241 
AM-MSCs showed a mean DT of 1.49±0.34 days/CD, significantly lower than that recorded 242 
for WJ-MSCs (1.71±0.65 days/CD; P<0.05). No statistically significant differences were 243 
found in DTs among earlier culture passages in both cell lines (P>0.05). However, AM-MSCs 244 
start to grow more slowly by P6, a sign of cellular aging; on the contrary, WJ-MSCs, despite 245 
an higher DT, get older later, starting from P7. This is confirmed by significantly higher DTs 246 
compared to the earliest steps (P<0.05). By P7, total WJ and AM-MSCs cell doublings were 247 
similar (36.57±0.76 vs 37.05±0.59; P>0.05; Fig.1).  248 
 249 
Adhesion and Migration Assays 250 
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Both AM and WJ cells formed spheroids when cultured in hanging drops. Average areas and 251 
volume of the spheroids formed by WJ-MSCs were significantly smaller than from AM-252 
MSCs (P<0.05; Fig.2). Average percentage of migration, observed by scratch test, was 253 
statistically similar between cell lines (AM-MSCs vs WJ-MSCs: 34.14±4.51% vs 254 
38.20±2.88%; P>0.05; Fig. 2). 255 
 256 
In vitro Differentiation 257 
Both cell lines were able to differentiate toward osteogenic, chondrogenic and adipogenic 258 
direction (Fig.3). However, WJ-MSCs showed a greater chondrogenic and osteogenic 259 
potential (P<0.05), characterized by a greater accumulation of extra-cellular mucosubstances 260 
and calcium deposits, as showed by Alcian Blu (Fig. 3A) and Von Kossa (Fig.3B) stains 261 
respectively. 262 
 263 
Immunostaining and PCR analysis  264 
Immunostaining results are showed in Figure 4. Amniotic membrane and WJ MSCs clearly 265 
expressed mesenchymal marker, N-Cadherin, and the mesodermal marker alpha-SMA. On the 266 
contrary, they did not express pan-cytokeratin and E-Cadherin.  267 
PCR results are reported in Table 4; positive expression are also showed in Figure 5. Both cell 268 
populations expressed MSC-associated markers (CD90, CD73), while were negative for an 269 
hematopoietic marker (CD45), at P3 of in vitro culture. On the contrary, the haematopoietic 270 
marker CD34 was registered for either population. Both WJ-MSCs and AMSCs lacked MHC-271 
I and MHC-II expression. Regarding embryonic markers, WJ-MSCs expressed OCT-4, while 272 
AM-MSCs were weakly positive for this marker; both cell populations lacked Nanog and 273 
Sox2. About their immune-phenotype, both WJ-MSCs and AMSCs lacked MHC-I, MHC-II, 274 
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INF- γ, TNF-α and IL-4 expression. Cell were instead positive for IL-6 and IL- β1. WJ-MSCs 275 
expressed IL-8 marker, while a weak expression was showed by AM-MSCs. 276 
 277 
TEM 278 
At low magnification, cells of both samples were quite small and uniform in size (diameter 279 
range: 10-15 µm; Fig. 6A; Fig. 7A). AM-MSCs appeared generally well dissociated, while 280 
WJ MSCs were frequently tightly adherent each other to form wide aggregates (Fig. 6A and 281 
B). Golgi complex was particularly well developed; it occupied a juxta-nuclear position and 282 
exhibited flattened cisternae, transport vesicles, and heterogeneous sized secreting granules. 283 
Some of them were very large and enclosed fine granular material (Fig. 6C and D). RER 284 
showed linear flat profiles and dilated cisternae (Fig. 6E and F). In both samples, the most 285 
interesting ultrastructural feature was represented by the very impressive number of large 286 
vesicular structures, up to 2 µm in diameter, scattered throughout the cytoplasm (Fig. 6G and 287 
H). They showed a variety of appearances and ranged from multivesicular bodies (MVB) 288 
(Fig. 7A and B) comprising intralumenal nanovesicles of different sizes (30-500 nm), to 289 
endolysosomes and autophagic vacuoles. They were particularly abundant in WJ-MSCs. The 290 
occurrence of membrane vesicles shedding from cell surface was observed in both samples. 291 
They ranged in size from 100 nm to 500 nm and included electron-lucent, as well as 292 
moderately electron-dense vesicles isolated or aggregated nearby the cells (Fig. 7C and D). 293 
Complex extracellular vesicles measuring 500nm-1µm and containing packed nanovesicles, 294 
frequently budded from the cell surface or were detected in the intercellular space (Fig. 7E 295 
and F). Tunneling nanotubes were occasionally observed in both samples suggesting that this 296 
may be an additional mechanism of crosstalk between MSCs (Fig. 7G and H). The most 297 
noteworthy difference between AM-MSCs and WJ-MSCs was the presence of an abundant 298 
extracellular fibrillar matrix (EFM) located in the intercellular spaces among WJ-MSCs (Fig. 299 
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8A-C). It was composed of a finely granular and moderately electron-dense ground substance 300 
populated by a loosely arranged network of reticular fibrils. These were uniformly thin and 301 
tend to run parallel to the cell surface. Abundant vesicles were entrapped among the fibrils 302 
(Fig. 8C). The intercellular spaces were devoid of collagen fibrils. 303 
 304 
Discussion 305 
AM-MSCs and WJ-MSCs are the focus of great interest in human and veterinary regenerative 306 
medicine for their in vitro multilineage differentiation potential, their great in vitro expansion 307 
(Iacono et al., 2012; Lange-Consiglio et al., 2013). In the present study, for the first time in 308 
equine species, proliferation, migration, spheroids formation, trilineage differentiation 309 
capacity, expression of stemness markers, immunophenotype and ultrastructural features of 310 
MSCs derived from WJ and AM were compared. From both tissues, cells with mesenchymal 311 
morphology were isolated. However, as recently reported in human (Subramanian et al., 312 
2015), in the present study, MSCs were isolated from all samples by collagenase digestion 313 
technique only for WJ. No other reports exist on the successful isolation rate from equine WJ 314 
and AM. Despite the lower isolation rate, AM-MSCs showed a higher proliferation rate 315 
compared to WJ-MSCs. As in human (Pasquinelli et al., 2007), in both cell types, TEM 316 
examination revealed an highly metabolic and synthetic nature, demonstrated by euchromatic 317 
nucleus, prominent nucleoli, abundant nuclear pores as well as by well-developed RER and 318 
Golgi complex. Furthermore, the higher DTs were unrelated with total cell doubling number, 319 
because AM-MSCs began to grow old earlier, as registered by a higher DT at P6 of in vitro 320 
culture, confirming the proliferative nature of WJ-MSCs. Beyond the growth curve, migration 321 
ability is an important feature of MSCs because of its fundamental significance for systemic 322 
application (Li et al., 2009; Burk et al., 2013). No differences were found between WJ-MSCs 323 
and AM-MSCs in migration ability. Since the adhesion capability is related and enhanced to 324 
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differentiation potential (Pasquinelli et al., 2007; Wang et al., 2009; Kavanagh et al., 2014), 325 
in the present study spheroid formation in vitro was assessed using the hanging drop method. 326 
Cell derived from WJ showed a higher adhesion ability, forming smaller spheroids, as 327 
determined by ReVisp. In the present study, the analysis of differentiated cells by Image J 328 
showed a higher WJ-MSCs chondrogenic and osteogenic potential. Our results confirmed 329 
data recently registered with human WJ-MSCs and AM-MSCs cell (Subramanian et al. 2015), 330 
in fact also equine WJ-MSCs, exposed to osteocyte and chondrocyte differentiation media, 331 
showed the highest number of Von Kossa stained cells, greatest staining intensity of nodules 332 
and higher number of cells positive for Alcian Blue compared to cells from AM 333 
(Subramanian et al., 2015). Besides to differentiation ability, the equine fetal adnexa derived 334 
MSCs demonstrate the characteristics defined by the International Society for Cellular 335 
Therapy criteria (Dominici et al., 2006), except for the CD34. CD34 is predominantly 336 
regarded as a marker of hematopoietic stem cells (HSC) and hematopoietic progenitor cells. 337 
Accumulating evidence demonstrates CD34 expression on several other cell types, including 338 
embryonic stem cell derived MSC (Kopher et al., 2010) and multipotent mesenchymal 339 
stromal cells (MSC) (Nielsen and McNagny, 2008). In many cases, CD34 indicate a distinct 340 
subset of cells with enhanced progenitor activity (Sidney et al., 2014). The expression of 341 
CD34 by equine cells might constitute evidence of their potenciality. Moreover, as 342 
intermediate between adult and embryonic cells, equine WJ and AM-MSCs express OCT-4, a 343 
marker for pluripotent stem cells. However, as previously reported in human (Subramanian et 344 
al., 2015), also in equine, the expression level of OCT-4 seems to be lower for cells from AM 345 
compared to WJ. This finding, coupled with greater differentiation ability, could be related to 346 
the middle position of WJ between blastocyst and adult. The stem cells isolated from the WJ 347 
probably start to lose their embryonic pluripotency tumorigenic characteristics and start to 348 
acquire multipotent non-tumorigenic MSC characteristics with progressive development. This 349 
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feature would help cells from the WJ to differentiate into specific lineages more easily both in 350 
vitro and during cell-based therapy and allow higher reprogramming efficiency to the 351 
embryonic state because of an immature phenotype (Pera et al., 2009). In human cells derived 352 
from WJ, the telomerase levels remained high throughout serial culture compared to AM-353 
MSCs suggesting that they retain their primitive characteristics in culture for long periods of 354 
time (Subramanian et al., 2015). In equine species further studies are needed to verify this 355 
condition. 356 
Due to the importance of MSCs for their immune response and their ability to suppress T-357 
cells (Carrade et al., 2012), in the present study, anti-inflammatory and pro-inflammatory 358 
factors produced both by WJ-MSCs and AM-MSCs were investigated for the first time in the 359 
horse. One of the most important cytokines of the acute phase reaction is TNF-α, while IL-4 360 
is a cytokine involved in allergic inflammation. Different from that observed in human cells, 361 
equine WJ and AM-MSCs do not express these markers, neither INF-γ when they are not 362 
stimulate in vitro by the presence of INF. Confirming their reduced immunogenicity, both cell 363 
lines were negative for MHC-I and MHC-II. On the contrary, both cell lines expressed, on 364 
their cDNA, IL-1β, IL-6 and IL-8; this cytokines are important mediator of the inflammatory 365 
response, involved in a variety of cellular activities, including cell proliferation, 366 
differentiation, apoptosis, chemotaxis, angiogenesis and hematopoiesis (Lamalice et al., 367 
2007). Data registered in this study confirmed those already reported in human WJ-MSCs  368 
(Dominici et al., 2006; Choi et al., 2013) and AM-MSCs (Yazdanpanah et al., 2015). These 369 
factors are involved in the complex interaction between MSCs and the tissue 370 
microenvironment as well as in the production of membrane vesicles, containing molecules 371 
such as short peptides, proteins, lipids, and various forms of RNAs (György et al., 2011). As 372 
previously observed in adult equine cells (Pascucci et al., 2014), the great number of MVB 373 
that, contained intralumenal vesicles maturing from their internal membrane, may be 374 
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interpreted as the ability of both cell types to produce a huge variety of “secreting” molecules 375 
enclosed inside vesicles of different types that are released in the extracellular milieu. Maybe 376 
hypothesized, in addition, that the several other vesicular structures observed by TEM 377 
represent a mechanism to efficiently recycle cell constituents by autophagy. The intense 378 
proliferating and metabolic activity, in fact, makes it necessary to constantly renew sub-379 
cellular components, especially membrane fractions. The main difference between AM-MSCs 380 
and WJ-MSCs attained the presence of an abundant extracellular fibrillar matrix in the 381 
intercellular spaces among WJ-MSCs; it probably determines a tight intercellular adhesion 382 
even after trypsin treatment and is responsible for the observation of cell aggregates at TEM 383 
analysis. It is well known that these cells, in vivo, are immersed in a mucoid connective 384 
matrix. It seems evident that WJ-MSC isolation and cultivation in vitro does not affect their 385 
ability to produce extracellular matrix. 386 
 387 
Conclusion 388 
It has emerged from the present study that cells isolated from different fetal origin matrices 389 
exhibit different morphological, molecular and differentiation potential. Equine WJ could be 390 
considered as a viable source for MSCs with reliable migration and differentiation capacities, 391 
and it is therefore a convenient cell source for autologous or allogeneic regenerative therapies. 392 
Although the molecular content and functional activities of EVs produced by WJ and AM-393 
MSCs remain to be characterized, the results of the present study indicated that MSCs from 394 
equine fetal adnexa are able to constitutively produce EVs that may be partly responsible for 395 
their paracrine activity. Further investigation are needed to find the best protocols for isolation 396 
and in vitro differentiation for AM-MSCs. Moreover, additional in vivo tests are needed to 397 
confirm our in vitro findings. 398 
 399 
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